- Published on
Emergency And Acute Medicine – Implantable Defibrillators
Basics And Description
An implantable cardioverter-defibrillator (ICD) is a small, battery-powered cardiac device implanted subcutaneously in patients at risk for sudden cardiac arrest due to malignant arrhythmias. One or more leads are positioned via venous access to the heart, typically endocardial in the right atrium and right ventricle, or epicardial via the coronary sinus to the left ventricle. The ICD detects atrial and ventricular arrhythmias and delivers electrical shocks between the generator (“can”) and coils in the right ventricle and superior vena cava/right atrial junction to restore sinus rhythm. Implantation technique is similar to pacemaker placement. Newer subcutaneous ICDs (S-ICD) avoid endocardial leads, reducing the risk of bloodstream infection. Approximately 450,000 sudden cardiac deaths occur annually in the United States, with over 100,000 ICDs implanted each year. ICDs reduce mortality more effectively than antiarrhythmic drugs in patients with left ventricular dysfunction, particularly when ejection fraction is below 35%, with an absolute mortality reduction of about 7% in the first two years. Benefit is demonstrated in ischemic and nonischemic dilated cardiomyopathy and hypertrophic cardiomyopathy.
Complications And Device Outcomes
Immediate postimplant complications include pneumothorax, vascular perforation, and acute lead dislodgement. Appropriate shocks occur in approximately 5% of patients annually for primary prevention and 20% annually for secondary prevention. Electrical storm is defined as two or more appropriate shocks within 24 hours. Inappropriate shocks occur in 10–20% of recipients and are commonly due to oversensing or misclassification of supraventricular tachycardia. Device infection occurs in 1–12% of patients, with acute infections (1–30 days) most often due to staphylococcal species and later infections commonly due to Staphylococcus epidermidis or gram-negative organisms. Mortality ranges from 31–66% if an infected device is not removed. Pocket hematomas should not be aspirated. Vascular occlusion related to leads may occur.
Etiology
Electrical storm may result from decompensated heart failure, acute ischemia, metabolic disturbances, drug-induced proarrhythmia, thyrotoxicosis, fever in dilated cardiomyopathy, genetic channelopathies (including Brugada syndrome, long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, and arrhythmogenic right ventricular cardiomyopathy), postcardiac surgery states, or ICD-induced pacing phenomena. Inappropriate shocks may result from oversensing of cardiac or noncardiac signals, electromagnetic interference, lead fracture, loose set screws, or header circuitry problems, as well as misclassification of atrial fibrillation, atrial flutter, sinus tachycardia, or other supraventricular tachycardias. Device- and site-related issues include wound infection, pocket hematoma, and venous thrombosis from lead-related venous obstruction.
Clinical Presentation
Patients who feel unwell before a shock and improved afterward likely received appropriate therapy. Patients who feel well before and after a shock likely experienced inappropriate therapy. Persistent symptoms before and after a shock suggest ongoing arrhythmia or ischemia. Appropriate shocks may be associated with syncope, near syncope, dizziness, dyspnea, palpitations, chest discomfort, or diaphoresis. Inappropriate shocks may occur with palpitations from supraventricular tachycardia or may be asymptomatic in lead-related malfunction. Device infection presents with fever, chills, malaise, hypotension, new murmur, or local wound findings such as erythema, warmth, purulent drainage, skin erosion, or fluctuance. Vascular complications present with unilateral upper-extremity swelling or superficial venous distention.
Evaluation And Workup
Following ICD therapy, device interrogation is essential to determine whether shocks were appropriate and to identify lead malfunction. A 12-lead ECG may show transient ST changes or enzyme elevation after shock delivery that do not necessarily represent myocardial injury. Chest radiography can identify lead fracture or dislodgement. Upper-extremity swelling suggests venous thrombosis. Laboratory evaluation includes cardiac enzymes when ischemia is suspected, complete blood count and blood cultures for infection, and coagulation studies when thrombosis is suspected. MRI is absolutely contraindicated. Magnet application inhibits tachyarrhythmia therapies but does not affect bradycardia pacing.
Differential Diagnosis
Consider appropriate ICD therapy for ventricular tachycardia or fibrillation, inappropriate therapy due to supraventricular tachycardia or device malfunction, phantom shocks perceived during sleep, acute coronary syndrome, heart failure exacerbation, and systemic infection.
Management And Treatment
Initial management follows standard advanced cardiac life support protocols with continuous monitoring. Electrical storm may require intravenous antiarrhythmic therapy such as amiodarone. Inappropriate shocks are managed by treating the underlying supraventricular arrhythmia with beta blockers or calcium channel blockers and inhibiting ICD therapies with magnet placement if needed. Device infections require prompt blood cultures and broad-spectrum antibiotics, with early consultation for device removal. External defibrillation is safe but should not be delivered directly over the ICD generator.
Medications
Common agents include intravenous amiodarone for ventricular arrhythmias, beta blockers or diltiazem for rate control, and antibiotics such as cefazolin or vancomycin for suspected device infection. Anticoagulation with warfarin is indicated for documented venous thrombosis.
Disposition And Follow-Up
Admission is required for patients with ongoing ischemia, heart failure, multiple ICD shocks, suspected infection, expanding pocket hematoma, need for lead revision, or upper-extremity thrombosis. Stable patients with a single appropriate shock and no evidence of ischemia or heart failure may be discharged with electrophysiology follow-up. Device-related complications require surgical or electrophysiology consultation prior to discharge.
Key Clinical Lessons And Common Errors
Aspiration of an ICD pocket should be avoided. External defibrillation pads should not be placed directly over the device, as this may shunt energy away from the myocardium. Prompt differentiation between appropriate and inappropriate shocks guides management and disposition.
Basics And Description
An implantable cardioverter-defibrillator (ICD) is a small, battery-powered cardiac device implanted subcutaneously in patients at risk for sudden cardiac arrest due to malignant arrhythmias. One or more leads are positioned via venous access to the heart, typically endocardial in the right atrium and right ventricle, or epicardial via the coronary sinus to the left ventricle. The ICD detects atrial and ventricular arrhythmias and delivers electrical shocks between the generator (“can”) and coils in the right ventricle and superior vena cava/right atrial junction to restore sinus rhythm. Implantation technique is similar to pacemaker placement. Newer subcutaneous ICDs (S-ICD) avoid endocardial leads, reducing the risk of bloodstream infection. Approximately 450,000 sudden cardiac deaths occur annually in the United States, with over 100,000 ICDs implanted each year. ICDs reduce mortality more effectively than antiarrhythmic drugs in patients with left ventricular dysfunction, particularly when ejection fraction is below 35%, with an absolute mortality reduction of about 7% in the first two years. Benefit is demonstrated in ischemic and nonischemic dilated cardiomyopathy and hypertrophic cardiomyopathy.
Complications And Device Outcomes
Immediate postimplant complications include pneumothorax, vascular perforation, and acute lead dislodgement. Appropriate shocks occur in approximately 5% of patients annually for primary prevention and 20% annually for secondary prevention. Electrical storm is defined as two or more appropriate shocks within 24 hours. Inappropriate shocks occur in 10–20% of recipients and are commonly due to oversensing or misclassification of supraventricular tachycardia. Device infection occurs in 1–12% of patients, with acute infections (1–30 days) most often due to staphylococcal species and later infections commonly due to Staphylococcus epidermidis or gram-negative organisms. Mortality ranges from 31–66% if an infected device is not removed. Pocket hematomas should not be aspirated. Vascular occlusion related to leads may occur.
Etiology
Electrical storm may result from decompensated heart failure, acute ischemia, metabolic disturbances, drug-induced proarrhythmia, thyrotoxicosis, fever in dilated cardiomyopathy, genetic channelopathies (including Brugada syndrome, long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, and arrhythmogenic right ventricular cardiomyopathy), postcardiac surgery states, or ICD-induced pacing phenomena. Inappropriate shocks may result from oversensing of cardiac or noncardiac signals, electromagnetic interference, lead fracture, loose set screws, or header circuitry problems, as well as misclassification of atrial fibrillation, atrial flutter, sinus tachycardia, or other supraventricular tachycardias. Device- and site-related issues include wound infection, pocket hematoma, and venous thrombosis from lead-related venous obstruction.
Clinical Presentation
Patients who feel unwell before a shock and improved afterward likely received appropriate therapy. Patients who feel well before and after a shock likely experienced inappropriate therapy. Persistent symptoms before and after a shock suggest ongoing arrhythmia or ischemia. Appropriate shocks may be associated with syncope, near syncope, dizziness, dyspnea, palpitations, chest discomfort, or diaphoresis. Inappropriate shocks may occur with palpitations from supraventricular tachycardia or may be asymptomatic in lead-related malfunction. Device infection presents with fever, chills, malaise, hypotension, new murmur, or local wound findings such as erythema, warmth, purulent drainage, skin erosion, or fluctuance. Vascular complications present with unilateral upper-extremity swelling or superficial venous distention.
Evaluation And Workup
Following ICD therapy, device interrogation is essential to determine whether shocks were appropriate and to identify lead malfunction. A 12-lead ECG may show transient ST changes or enzyme elevation after shock delivery that do not necessarily represent myocardial injury. Chest radiography can identify lead fracture or dislodgement. Upper-extremity swelling suggests venous thrombosis. Laboratory evaluation includes cardiac enzymes when ischemia is suspected, complete blood count and blood cultures for infection, and coagulation studies when thrombosis is suspected. MRI is absolutely contraindicated. Magnet application inhibits tachyarrhythmia therapies but does not affect bradycardia pacing.
Differential Diagnosis
Consider appropriate ICD therapy for ventricular tachycardia or fibrillation, inappropriate therapy due to supraventricular tachycardia or device malfunction, phantom shocks perceived during sleep, acute coronary syndrome, heart failure exacerbation, and systemic infection.
Management And Treatment
Initial management follows standard advanced cardiac life support protocols with continuous monitoring. Electrical storm may require intravenous antiarrhythmic therapy such as amiodarone. Inappropriate shocks are managed by treating the underlying supraventricular arrhythmia with beta blockers or calcium channel blockers and inhibiting ICD therapies with magnet placement if needed. Device infections require prompt blood cultures and broad-spectrum antibiotics, with early consultation for device removal. External defibrillation is safe but should not be delivered directly over the ICD generator.
Medications
Common agents include intravenous amiodarone for ventricular arrhythmias, beta blockers or diltiazem for rate control, and antibiotics such as cefazolin or vancomycin for suspected device infection. Anticoagulation with warfarin is indicated for documented venous thrombosis.
Disposition And Follow-Up
Admission is required for patients with ongoing ischemia, heart failure, multiple ICD shocks, suspected infection, expanding pocket hematoma, need for lead revision, or upper-extremity thrombosis. Stable patients with a single appropriate shock and no evidence of ischemia or heart failure may be discharged with electrophysiology follow-up. Device-related complications require surgical or electrophysiology consultation prior to discharge.
Key Clinical Lessons And Common Errors
Aspiration of an ICD pocket should be avoided. External defibrillation pads should not be placed directly over the device, as this may shunt energy away from the myocardium. Prompt differentiation between appropriate and inappropriate shocks guides management and disposition.
0 Comments
